| Property | Value |
|---|---|
| Protein Name | PIK3C3 / VPS34 |
| Gene Symbol | PIK3C3 |
| UniProt ID | Q8N3F7 |
| Molecular Weight | ~100 kDa (887 aa) |
| Chromosomal Location | 18q12.3 |
| Subcellular Localization | Cytosol, endosomal membrane, phagophore |
| Protein Family | Class III Phosphoinositide 3-kinase (PI3K3C) |
| Brain Expression | High in neurons, particularly cortex and hippocampus |
PIK3C3, also known as VPS34 (Vacuolar Protein Sorting 34), is the catalytic subunit of the sole class III phosphoinositide 3-kinase (PI3K) in mammals. It plays a central and essential role in autophagy and endosomal trafficking by phosphorylating phosphatidylinositol to produce phosphatidylinositol 3-phosphate (PI3P) [1]. Unlike class I PI3Ks that regulate cell growth and survival, PIK3C3 is dedicated to membrane trafficking and organelle homeostasis, making it critical for neuronal function and survival.
The discovery that PIK3C3 variants cause neurodegenerative disorders, including hereditary spastic paraplegia, cerebellar atrophy, and atypical parkinsonism, has highlighted its importance in the central nervous system [2]. PIK3C3 dysfunction contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis through impaired autophagic clearance of protein aggregates and damaged organelles [3].
The discovery that PIK3C3 variants cause neurodegenerative disorders, including hereditary spastic paraplegia, cerebellar atrophy, and atypical parkinsonism, has highlighted its importance in the central nervous system [2:1]. PIK3C3 dysfunction contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis through impaired autophagic clearance of protein aggregates and damaged organelles [3:1].
The human PIK3C3 gene is located on chromosome 18q12.3 and spans approximately 30 kb. It consists of 32 exons that encode the 887-amino acid PIK3C3 protein. Multiple transcript variants are produced through alternative splicing, with the canonical isoform (Isoform 1) being the predominant form in neuronal tissue.
PIK3C3 adopts a characteristic phosphatidylinositol 3-kinase domain architecture [@kumar2018]:
N-terminal Helical Domain (aa 1-150): This domain mediates interaction with the regulatory subunit VPS15 and facilitates proper subcellular localization. It contains a unique region that directs the protein to autophagosomes and endosomes.
C2 Domain (aa 200-320): The C2 domain targets PIK3C3 to membrane surfaces by binding phospholipids in a calcium-independent manner. This domain is critical for recruitment to isolation membranes during autophagosome biogenesis.
Kinase Domain (aa 400-887): The catalytic domain phosphorylates the 3-hydroxyl group of phosphatidylinositol (PI) and phosphatidylinositol 4-phosphate (PI4P), though PI is the preferred substrate. The kinase domain contains the activation loop and P-loop motifs essential for ATP binding and catalysis.
Crystal and cryo-EM structures of PIK3C3 have revealed:
PIK3C3/VPS34 is the master regulator of autophagy initiation [@itakura2016]:
PI3P Production: PIK3C3 generates PI3P on the surface of the isolation membrane (phagophore), the precursor to the autophagosome. This lipid modification is the defining feature of nascent autophagosomes and is essential for their formation.
PI3P Effectors: PI3P recruits multiple autophagy proteins including WIPI1, WIPI2, DFCP1, and ATG14. These proteins coordinate the recruitment of the ATG12-ATG5-ATG16L1 conjugation system, which mediates lipidation of LC3 (MAP1LC3A).
Autophagosome Formation: PIK3C3 activity is required for the nucleation and expansion of the autophagosome. Without PI3P production, the isolation membrane cannot form properly, and autophagosome biogenesis fails.
Beyond autophagy, PIK3C3 regulates endosomal maturation and sorting [4]:
Endosomal Maturation: PIK3C3-generated PI3P is required for the conversion of early endosomes to late endosomes. This involves the recruitment of the HOPS complex, which mediates tethering and fusion with lysosomes.
Cargo Sorting: PI3P on endosomal membranes directs the sorting of cargo for degradation or recycling. Defects in this process lead to the accumulation of endosomal vesicles and impaired nutrient recycling.
Lysosomal Function: PIK3C3 contributes to lysosomal biogenesis and function through its role in autophagosome-lysosome fusion. The protein interacts with the HOPS complex via VPS34-generated PI3P.
Multiple mechanisms regulate PIK3C3 function:
Complex Formation: PIK3C3 functions as part of a heterotetrameric complex with VPS15 (p150), VPS30/Beclin 1, and either ATG14 or UVRAG. This association is essential for its stability and activity.
Phosphorylation: VPS15 phosphorylates PIK3C3 at multiple sites, enhancing its activity. Additional kinases including AMPK and mTOR regulate PIK3C3 indirectly through the upstream autophagy machinery.
Lipid Regulation: PIK3C3 activity is modulated by membrane lipid composition. Phosphatidic acid and other lipids can activate PIK3C3, while certain phosphoinositides inhibit its activity.
PIK3C3 dysfunction is increasingly recognized as a contributor to PD pathogenesis [@chen2020]:
Genetic Evidence:
Autophagy Impairment:
VPS35 Interaction: VPS35, a component of the retromer complex, directly interacts with PIK3C3 pathway components [@rui2015]. VPS35 mutations (D620N) cause familial PD and impair endosomal trafficking and autophagy.
Therapeutic Implications:
PIK3C3 contributes to AD pathogenesis through multiple mechanisms [@zhang2017]:
Amyloid Metabolism:
Tau Pathology:
Synaptic Dysfunction:
PIK3C3 dysfunction contributes to ALS/FTD pathogenesis [@javaheri2020]:
TDP-43 Pathology:
Protein Aggregate Clearance:
Therapeutic Potential:
PIK3C3 functions at the apex of the autophagy pathway:
PIK3C3 regulates the endosomal-lysosomal network:
Drug discovery efforts target PIK3C3 activation:
Viral vector delivery of PIK3C3 shows promise:
Clinical validation of PIK3C3 as a therapeutic target:
Study of PIK3C3 employs various techniques:
Pik3c3 Null Mice:
Conditional Knockouts:
Pik3c3 Overexpression:
Backer et al. VPS34 PI3-kinase function (2016). 2016. ↩︎
Miller et al. PIK3C3 in Parkinson's disease (2020). 2020. ↩︎ ↩︎
Wang et al. Autophagy in neurodegeneration (2019). 2019. ↩︎ ↩︎
Niemann et al. VPS34 and lysosomal trafficking (2006). 2006. ↩︎